Advancing transdermal drug-delivery systems past development barriers to the clinic: an industry perspective

被引：10

作者：

Quan, Danyi ^{[1
]}

机构：

[1] Xel Pharmaceut Inc, 12382 Gateway Pk Pl,Suite B600, Draper, UT 84020 USA

来源：

THERAPEUTIC DELIVERY | 2012年 / 3卷 / 03期

关键词：

active transdermal delivery; passive transdermal delivery; Quality-by-Design; trasndermal drug delivery;

D O I：

10.4155/TDE.12.5

中图分类号：

R9 [药学];

学科分类号：

1007 [药学];

摘要：

In order to increase the quality of transdermal drug-delivery systems, it [quality] must be built into the systemic product development.

引用

页码：299 / 301

页数：3

共 11 条

[1]

Dubin CH, 2011, DRUG DELIV TECHNOL, V11, P22

[2]

Hadgraft J., 2006, AM J DRUG DELIV, V4, P153, DOI [10.2165/00137696-200604030-00003, DOI 10.2165/00137696-200604030-00003]

[3]

Quality by design: Concepts for ANDAs [J].

Lionberger, Robert A. ;

Lee, Sau Lawrence ;

Lee, LaiMing ;

Raw, Andre ;

Yu, Lawrence X. .

AAPS JOURNAL, 2008, 10 (02) :268-276

[4]

Challenges and opportunities in dermal/transdermal delivery [J].

Paudel, Kalpana S. ;

Milewski, Mikolaj ;

Swadley, Courtney L. ;

Brogden, Nicole K. ;

Ghosh, Priyanka ;

Stinchcomb, Audra L. .

THERAPEUTIC DELIVERY, 2010, 1 (01) :109-131

[5]

Transdermal drug delivery [J].

Prausnitz, Mark R. ;

Langer, Robert .

NATURE BIOTECHNOLOGY, 2008, 26 (11) :1261-1268

[6]

Quan D., 2010, TRANSDERMAL MAG 1, V2, P8

[7]

Quan D., 2010, TRANSDERMAL MAG 2, V2, P10

[8]

Quan D., 2010, TRANSDERMAL MAG 1, V2, P5

[9]

Quan D., 2011, TRANSDERMAL MAGAZINE, V3, P6

[10]

Yeoh T., 2011, TRANSDERMAL MAG, V3, P10

← 1 2 →